KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Colgate Palmolive (CL) over the last 15 years, with Q3 2025 value amounting to $72.0 million.

  • Colgate Palmolive's Share-based Compensation rose 1076.92% to $72.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $154.0 million, marking a year-over-year increase of 1578.95%. This contributed to the annual value of $135.0 million for FY2024, which is 1065.57% up from last year.
  • Latest data reveals that Colgate Palmolive reported Share-based Compensation of $72.0 million as of Q3 2025, which was up 1076.92% from $32.0 million recorded in Q2 2025.
  • In the past 5 years, Colgate Palmolive's Share-based Compensation registered a high of $72.0 million during Q3 2025, and its lowest value of $14.0 million during Q1 2023.
  • Moreover, its 5-year median value for Share-based Compensation was $27.0 million (2024), whereas its average is $33.9 million.
  • In the last 5 years, Colgate Palmolive's Share-based Compensation skyrocketed by 13750.0% in 2021 and then tumbled by 5172.41% in 2023.
  • Colgate Palmolive's Share-based Compensation (Quarter) stood at $28.0 million in 2021, then dropped by 28.57% to $20.0 million in 2022, then rose by 25.0% to $25.0 million in 2023, then grew by 8.0% to $27.0 million in 2024, then surged by 166.67% to $72.0 million in 2025.
  • Its last three reported values are $72.0 million in Q3 2025, $32.0 million for Q2 2025, and $23.0 million during Q1 2025.